Miami Cancer Institute – Lung Cancer Conference Evaluation - November 2, 2021

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

As a result of attending this conference, to what extent do you agree that you will be better able to: (rate the objectives) *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	N/A
Assess the clinical efficacy of postoperative noninvasive positive pressure ventilation after pulmonary lobectomy.	Assess the clinical efficacy of postoperative noninvasive positive pressure ventilation after pulmonary lobectomy. - 5	Assess the clinical efficacy of postoperative noninvasive positive pressure ventilation after pulmonary lobectomy. - 4	Assess the clinical efficacy of postoperative noninvasive positive pressure ventilation after pulmonary lobectomy. - 3	Assess the clinical efficacy of postoperative noninvasive positive pressure ventilation after pulmonary lobectomy. - 2	Assess the clinical efficacy of postoperative noninvasive positive pressure ventilation after pulmonary lobectomy. - 1	Assess the clinical efficacy of postoperative noninvasive positive pressure ventilation after pulmonary lobectomy. - N/A
Develop selective strategies for determining the appropriate extent of resection for individual patients to reduce organ loss.	Develop selective strategies for determining the appropriate extent of resection for individual patients to reduce organ loss. - 5	Develop selective strategies for determining the appropriate extent of resection for individual patients to reduce organ loss. - 4	Develop selective strategies for determining the appropriate extent of resection for individual patients to reduce organ loss. - 3	Develop selective strategies for determining the appropriate extent of resection for individual patients to reduce organ loss. - 2	Develop selective strategies for determining the appropriate extent of resection for individual patients to reduce organ loss. - 1	Develop selective strategies for determining the appropriate extent of resection for individual patients to reduce organ loss. - N/A
Assess the outcomes of patients experiencing complications after robotic pulmonary resection.	Assess the outcomes of patients experiencing complications after robotic pulmonary resection. - 5	Assess the outcomes of patients experiencing complications after robotic pulmonary resection. - 4	Assess the outcomes of patients experiencing complications after robotic pulmonary resection. - 3	Assess the outcomes of patients experiencing complications after robotic pulmonary resection. - 2	Assess the outcomes of patients experiencing complications after robotic pulmonary resection. - 1	Assess the outcomes of patients experiencing complications after robotic pulmonary resection. - N/A
Identify treatment-related factors associated with an increased risk of major complications.	Identify treatment-related factors associated with an increased risk of major complications. - 5	Identify treatment-related factors associated with an increased risk of major complications. - 4	Identify treatment-related factors associated with an increased risk of major complications. - 3	Identify treatment-related factors associated with an increased risk of major complications. - 2	Identify treatment-related factors associated with an increased risk of major complications. - 1	Identify treatment-related factors associated with an increased risk of major complications. - N/A
Identify the benefits of robotic intervention versus thoracotomy or conventional VATS techniques.	Identify the benefits of robotic intervention versus thoracotomy or conventional VATS techniques. - 5	Identify the benefits of robotic intervention versus thoracotomy or conventional VATS techniques. - 4	Identify the benefits of robotic intervention versus thoracotomy or conventional VATS techniques. - 3	Identify the benefits of robotic intervention versus thoracotomy or conventional VATS techniques. - 2	Identify the benefits of robotic intervention versus thoracotomy or conventional VATS techniques. - 1	Identify the benefits of robotic intervention versus thoracotomy or conventional VATS techniques. - N/A
Describe morbidity and mortality rate of complete resection associated with robotic surgery in the treatment of lung cancer.	Describe morbidity and mortality rate of complete resection associated with robotic surgery in the treatment of lung cancer. - 5	Describe morbidity and mortality rate of complete resection associated with robotic surgery in the treatment of lung cancer. - 4	Describe morbidity and mortality rate of complete resection associated with robotic surgery in the treatment of lung cancer. - 3	Describe morbidity and mortality rate of complete resection associated with robotic surgery in the treatment of lung cancer. - 2	Describe morbidity and mortality rate of complete resection associated with robotic surgery in the treatment of lung cancer. - 1	Describe morbidity and mortality rate of complete resection associated with robotic surgery in the treatment of lung cancer. - N/A
Identify the principles of stereotactic body radiotherapy for early-stage non-small cell lung cancer.	Identify the principles of stereotactic body radiotherapy for early-stage non-small cell lung cancer. - 5	Identify the principles of stereotactic body radiotherapy for early-stage non-small cell lung cancer. - 4	Identify the principles of stereotactic body radiotherapy for early-stage non-small cell lung cancer. - 3	Identify the principles of stereotactic body radiotherapy for early-stage non-small cell lung cancer. - 2	Identify the principles of stereotactic body radiotherapy for early-stage non-small cell lung cancer. - 1	Identify the principles of stereotactic body radiotherapy for early-stage non-small cell lung cancer. - N/A
Analyze and assess outcomes for nonoperative management of locally advanced non-small cell lung cancer.	Analyze and assess outcomes for nonoperative management of locally advanced non-small cell lung cancer. - 5	Analyze and assess outcomes for nonoperative management of locally advanced non-small cell lung cancer. - 4	Analyze and assess outcomes for nonoperative management of locally advanced non-small cell lung cancer. - 3	Analyze and assess outcomes for nonoperative management of locally advanced non-small cell lung cancer. - 2	Analyze and assess outcomes for nonoperative management of locally advanced non-small cell lung cancer. - 1	Analyze and assess outcomes for nonoperative management of locally advanced non-small cell lung cancer. - N/A
Accurately assess and execute a thorough workup of a solitary lung nodule.	Accurately assess and execute a thorough workup of a solitary lung nodule. - 5	Accurately assess and execute a thorough workup of a solitary lung nodule. - 4	Accurately assess and execute a thorough workup of a solitary lung nodule. - 3	Accurately assess and execute a thorough workup of a solitary lung nodule. - 2	Accurately assess and execute a thorough workup of a solitary lung nodule. - 1	Accurately assess and execute a thorough workup of a solitary lung nodule. - N/A
Differentiate and evaluate treatment approaches of a lung nodule versus sampled nodule and when to proceed with surgical resection.	Differentiate and evaluate treatment approaches of a lung nodule versus sampled nodule and when to proceed with surgical resection. - 5	Differentiate and evaluate treatment approaches of a lung nodule versus sampled nodule and when to proceed with surgical resection. - 4	Differentiate and evaluate treatment approaches of a lung nodule versus sampled nodule and when to proceed with surgical resection. - 3	Differentiate and evaluate treatment approaches of a lung nodule versus sampled nodule and when to proceed with surgical resection. - 2	Differentiate and evaluate treatment approaches of a lung nodule versus sampled nodule and when to proceed with surgical resection. - 1	Differentiate and evaluate treatment approaches of a lung nodule versus sampled nodule and when to proceed with surgical resection. - N/A
Evaluate bronchoscopic techniques, radial endobronchial ultrasound, navigation bronchoscopy, electromagnetic navigation and robotic platforms.	Evaluate bronchoscopic techniques, radial endobronchial ultrasound, navigation bronchoscopy, electromagnetic navigation and robotic platforms. - 5	Evaluate bronchoscopic techniques, radial endobronchial ultrasound, navigation bronchoscopy, electromagnetic navigation and robotic platforms. - 4	Evaluate bronchoscopic techniques, radial endobronchial ultrasound, navigation bronchoscopy, electromagnetic navigation and robotic platforms. - 3	Evaluate bronchoscopic techniques, radial endobronchial ultrasound, navigation bronchoscopy, electromagnetic navigation and robotic platforms. - 2	Evaluate bronchoscopic techniques, radial endobronchial ultrasound, navigation bronchoscopy, electromagnetic navigation and robotic platforms. - 1	Evaluate bronchoscopic techniques, radial endobronchial ultrasound, navigation bronchoscopy, electromagnetic navigation and robotic platforms. - N/A
Describe results of recent clinical trials that combine targeted therapies with chemotherapy.	Describe results of recent clinical trials that combine targeted therapies with chemotherapy. - 5	Describe results of recent clinical trials that combine targeted therapies with chemotherapy. - 4	Describe results of recent clinical trials that combine targeted therapies with chemotherapy. - 3	Describe results of recent clinical trials that combine targeted therapies with chemotherapy. - 2	Describe results of recent clinical trials that combine targeted therapies with chemotherapy. - 1	Describe results of recent clinical trials that combine targeted therapies with chemotherapy. - N/A
Implement strategies that optimize therapeutic decisions for patients based on individual molecular, genomic and clinical features.	Implement strategies that optimize therapeutic decisions for patients based on individual molecular, genomic and clinical features. - 5	Implement strategies that optimize therapeutic decisions for patients based on individual molecular, genomic and clinical features. - 4	Implement strategies that optimize therapeutic decisions for patients based on individual molecular, genomic and clinical features. - 3	Implement strategies that optimize therapeutic decisions for patients based on individual molecular, genomic and clinical features. - 2	Implement strategies that optimize therapeutic decisions for patients based on individual molecular, genomic and clinical features. - 1	Implement strategies that optimize therapeutic decisions for patients based on individual molecular, genomic and clinical features. - N/A
Analyze current strategies and standard of care for proper pretreatment molecular and PDL-1 testing.	Analyze current strategies and standard of care for proper pretreatment molecular and PDL-1 testing. - 5	Analyze current strategies and standard of care for proper pretreatment molecular and PDL-1 testing. - 4	Analyze current strategies and standard of care for proper pretreatment molecular and PDL-1 testing. - 3	Analyze current strategies and standard of care for proper pretreatment molecular and PDL-1 testing. - 2	Analyze current strategies and standard of care for proper pretreatment molecular and PDL-1 testing. - 1	Analyze current strategies and standard of care for proper pretreatment molecular and PDL-1 testing. - N/A
Execute appropriate treatment with immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer.	Execute appropriate treatment with immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer. - 5	Execute appropriate treatment with immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer. - 4	Execute appropriate treatment with immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer. - 3	Execute appropriate treatment with immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer. - 2	Execute appropriate treatment with immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer. - 1	Execute appropriate treatment with immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer. - N/A
Integrate gene mapping into professional practice updates when treating lung cancer.	Integrate gene mapping into professional practice updates when treating lung cancer. - 5	Integrate gene mapping into professional practice updates when treating lung cancer. - 4	Integrate gene mapping into professional practice updates when treating lung cancer. - 3	Integrate gene mapping into professional practice updates when treating lung cancer. - 2	Integrate gene mapping into professional practice updates when treating lung cancer. - 1	Integrate gene mapping into professional practice updates when treating lung cancer. - N/A
Identify the most effective treatment plan as a result of gene mapping.	Identify the most effective treatment plan as a result of gene mapping. - 5	Identify the most effective treatment plan as a result of gene mapping. - 4	Identify the most effective treatment plan as a result of gene mapping. - 3	Identify the most effective treatment plan as a result of gene mapping. - 2	Identify the most effective treatment plan as a result of gene mapping. - 1	Identify the most effective treatment plan as a result of gene mapping. - N/A
Identify new treatments for resectable lung cancer.	Identify new treatments for resectable lung cancer. - 5	Identify new treatments for resectable lung cancer. - 4	Identify new treatments for resectable lung cancer. - 3	Identify new treatments for resectable lung cancer. - 2	Identify new treatments for resectable lung cancer. - 1	Identify new treatments for resectable lung cancer. - N/A

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
John Roberts, M.D. - The Value of Minimally Invasive Pulmonary Surgery	John Roberts, M.D. - The Value of Minimally Invasive Pulmonary Surgery - 5	John Roberts, M.D. - The Value of Minimally Invasive Pulmonary Surgery - 4	John Roberts, M.D. - The Value of Minimally Invasive Pulmonary Surgery - 3	John Roberts, M.D. - The Value of Minimally Invasive Pulmonary Surgery - 2	John Roberts, M.D. - The Value of Minimally Invasive Pulmonary Surgery - 1
John De Rosimo, M.D. - The ABC’s of Robotic-Assisted Pulmonary Resection	John De Rosimo, M.D. - The ABC’s of Robotic-Assisted Pulmonary Resection - 5	John De Rosimo, M.D. - The ABC’s of Robotic-Assisted Pulmonary Resection - 4	John De Rosimo, M.D. - The ABC’s of Robotic-Assisted Pulmonary Resection - 3	John De Rosimo, M.D. - The ABC’s of Robotic-Assisted Pulmonary Resection - 2	John De Rosimo, M.D. - The ABC’s of Robotic-Assisted Pulmonary Resection - 1
Mark Dylewski, M.D. - Robotic Assisted Pulmonary Resection	Mark Dylewski, M.D. - Robotic Assisted Pulmonary Resection - 5	Mark Dylewski, M.D. - Robotic Assisted Pulmonary Resection - 4	Mark Dylewski, M.D. - Robotic Assisted Pulmonary Resection - 3	Mark Dylewski, M.D. - Robotic Assisted Pulmonary Resection - 2	Mark Dylewski, M.D. - Robotic Assisted Pulmonary Resection - 1
Rupesh Kotecha, M.D. - Treatment of Early-Stage and Advanced Lung Cancer	Rupesh Kotecha, M.D. - Treatment of Early-Stage and Advanced Lung Cancer - 5	Rupesh Kotecha, M.D. - Treatment of Early-Stage and Advanced Lung Cancer - 4	Rupesh Kotecha, M.D. - Treatment of Early-Stage and Advanced Lung Cancer - 3	Rupesh Kotecha, M.D. - Treatment of Early-Stage and Advanced Lung Cancer - 2	Rupesh Kotecha, M.D. - Treatment of Early-Stage and Advanced Lung Cancer - 1
Andres Sosa, M.D. - Evaluation of Pulmonary Nodules	Andres Sosa, M.D. - Evaluation of Pulmonary Nodules - 5	Andres Sosa, M.D. - Evaluation of Pulmonary Nodules - 4	Andres Sosa, M.D. - Evaluation of Pulmonary Nodules - 3	Andres Sosa, M.D. - Evaluation of Pulmonary Nodules - 2	Andres Sosa, M.D. - Evaluation of Pulmonary Nodules - 1
Raul Valor, M.D. - Advanced Therapeutic Bronchoscopy for the Treatment of Lung Cancer	Raul Valor, M.D. - Advanced Therapeutic Bronchoscopy for the Treatment of Lung Cancer - 5	Raul Valor, M.D. - Advanced Therapeutic Bronchoscopy for the Treatment of Lung Cancer - 4	Raul Valor, M.D. - Advanced Therapeutic Bronchoscopy for the Treatment of Lung Cancer - 3	Raul Valor, M.D. - Advanced Therapeutic Bronchoscopy for the Treatment of Lung Cancer - 2	Raul Valor, M.D. - Advanced Therapeutic Bronchoscopy for the Treatment of Lung Cancer - 1
Paul Kaywin, M.D. - Treatment of Advanced-Stage Lung Cancer with Traditional Chemotherapy and The Role of Immunotherapy	Paul Kaywin, M.D. - Treatment of Advanced-Stage Lung Cancer with Traditional Chemotherapy and The Role of Immunotherapy - 5	Paul Kaywin, M.D. - Treatment of Advanced-Stage Lung Cancer with Traditional Chemotherapy and The Role of Immunotherapy - 4	Paul Kaywin, M.D. - Treatment of Advanced-Stage Lung Cancer with Traditional Chemotherapy and The Role of Immunotherapy - 3	Paul Kaywin, M.D. - Treatment of Advanced-Stage Lung Cancer with Traditional Chemotherapy and The Role of Immunotherapy - 2	Paul Kaywin, M.D. - Treatment of Advanced-Stage Lung Cancer with Traditional Chemotherapy and The Role of Immunotherapy - 1
Matthen Mathew, M.D. - “It’s all in the Genes”: However Genetics Is Changing the Face of Treatment for Lung Cancer	Matthen Mathew, M.D. - “It’s all in the Genes”: However Genetics Is Changing the Face of Treatment for Lung Cancer - 5	Matthen Mathew, M.D. - “It’s all in the Genes”: However Genetics Is Changing the Face of Treatment for Lung Cancer - 4	Matthen Mathew, M.D. - “It’s all in the Genes”: However Genetics Is Changing the Face of Treatment for Lung Cancer - 3	Matthen Mathew, M.D. - “It’s all in the Genes”: However Genetics Is Changing the Face of Treatment for Lung Cancer - 2	Matthen Mathew, M.D. - “It’s all in the Genes”: However Genetics Is Changing the Face of Treatment for Lung Cancer - 1
Frederico Albrecht, M.D. - Update on the Role of Neoadjuvant Chemotherapy	Frederico Albrecht, M.D. - Update on the Role of Neoadjuvant Chemotherapy - 5	Frederico Albrecht, M.D. - Update on the Role of Neoadjuvant Chemotherapy - 4	Frederico Albrecht, M.D. - Update on the Role of Neoadjuvant Chemotherapy - 3	Frederico Albrecht, M.D. - Update on the Role of Neoadjuvant Chemotherapy - 2	Frederico Albrecht, M.D. - Update on the Role of Neoadjuvant Chemotherapy - 1

Was this course fair, balanced and without commercial bias? *

Yes

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so? *

Please provide any additional comments or suggestions.

Name

Leave this field blank

You are here

Miami Cancer Institute – Lung Cancer Conference Evaluation - November 2, 2021